A Clinical Trial for Examining the Therapeutic Equivalence Between Fluticasone Propionate 100 mcg and Salmeterol 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS® 100/50 mcg Inhalation Powder/GSK in Patients With Asthma
Clinical trial NCT03676413 · COMPLETED
Trial details
- NCT number
- NCT03676413
- Sponsor
- Respirent Pharmaceuticals Co Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-02
- Primary completion
- 2019-08-02
- Enrollment
- 451
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.